Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Technology entities : Alnylam pharmaceuticals, inc. save search
RNAi Technology Global Market to Reach $3.5 Billion by 2028 at a CAGR of 10.1%
Published: 2022-12-12 (Crawled : 22:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: 2.32%
H: 0.0%
C: 0.0%
SLN | $21.98 1.95% 1.91% 120K
|
Health Technology
|
| O: 1.63%
H: 13.76%
C: -6.11%
PHIO | $0.63 -2.93% -3.02% 62K
|
Health Technology
|
| O: -4.12%
H: 6.87%
C: 1.78%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 1.46%
H: 0.99%
C: -0.97%
global technology market
Alnylam Announces Publication of Preclinical Results Based on Novel Conjugate Technology That Facilitates Delivery of Short Interfering RNA to the Central Nervous System and Other Extrahepatic Tissues
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -2.55%
H: 0.0%
C: -0.12%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.4%
H: 2.47%
C: 2.4%
system preclinical technology results publication pre-clinical
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
VIR | $7.96 -3.52% -3.64% 880K
|
Health Technology
|
| O: -6.87%
H: 0.0%
C: 0.0%
GILD | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -2.95%
H: 0.0%
C: 0.0%
financial results technology report results biotech iot
Ceptur Therapeutics Launches with $75M Series A Financing to Advance RNA Therapeutics Based on Proprietary U1 Adaptor Technology
Published: 2022-01-19 (Crawled : 13:00) - biospace.com/
STOK | News | $11.66 -0.51% -0.51% 1.1M
|
Health Technology
|
| O: -1.31%
H: 2.13%
C: -3.48%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -2.91%
H: 2.06%
C: -1.88%
technology therapeutics
n-Lorem Foundation Partners with Alnylam to Expand Technology Access to RNAi Therapeutics for Patients with Nano-rare Diseases
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -2.0%
H: 0.0%
C: 0.0%
rare technology therapeutics disease
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection at AASLD The Liver Meeting®
Published: 2021-11-12 (Crawled : 13:15) - globenewswire.com
VIR | $7.96 -3.52% -3.64% 880K
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: 0.0%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -2.06%
H: 0.0%
C: 0.0%
hepatitis potential biotech technology iot liver injection infections chronic hepatitis b
Alnylam Receives Positive Reimbursement Recommendation from the Canadian Agencies for Drugs and Technology in Health (CADTH) for use of GIVLAARI for the Treatment of Acute Hepatic Porphyria (AHP) in Adults
Published: 2021-10-18 (Crawled : 18:00) - biospace.com/
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -2.37%
treatment positive drug technology hepatitis
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at AASLD’s The Liver Meeting® 2021
Published: 2021-10-15 (Crawled : 14:00) - biospace.com/
VIR | $7.96 -3.52% -3.64% 880K
|
Health Technology
|
| O: -0.02%
H: 3.08%
C: -2.81%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 0.34%
H: 0.09%
C: -0.69%
presentation hepatitis biotech technology iot liver
Vir Biotechnology Initiates Phase 2 Clinical Trial Evaluating the Combination of VIR-2218 and VIR-3434 as a Functional Cure Regimen for Chronic Hepatitis B Virus Infection
Published: 2021-07-15 (Crawled : 14:00) - biospace.com/
VIR | $7.96 -3.52% -3.64% 880K
|
Health Technology
|
| O: 0.08%
H: 2.71%
C: 2.31%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.16%
H: 1.35%
C: 1.11%
phase 2 hepatitis biotech technology iot trial injection infections chronic hepatitis b
Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021
Published: 2021-06-25 (Crawled : 13:00) - globenewswire.com
VIR | $7.96 -3.52% -3.64% 880K
|
Health Technology
|
| O: -0.52%
H: 1.36%
C: -7.74%
GILD | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -0.06%
H: 1.28%
C: 1.1%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 0.26%
H: 1.5%
C: 0.72%
hepatitis ongoing biotech technology iot liver trial injection infections chronic hepatitis b
Immuneering Expands Board of Directors with Addition of Senior Biotechnology Executive Laurie Keating
Published: 2021-04-27 (Crawled : 19:00) - biospace.com/
TAK | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.65%
H: 0.06%
C: -0.24%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.53%
H: 1.35%
C: -0.59%
biotech technology iot
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
Published: 2021-04-21 (Crawled : 12:00) - vbivaccines.com
VIR | $7.96 -3.52% -3.64% 880K
|
Health Technology
|
| O: -1.09%
H: 0.38%
C: 0.04%
VBIV | $0.6001 -1.46% -1.48% 180K
|
Health Technology
|
| O: 0.0%
H: 7.66%
C: 7.66%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 0.67%
H: 1.12%
C: 0.43%
treatment phase 2 hepatitis vbi-2601 biotech vaccine technology iot brii-835 trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.